|Número de publicación||US3801675 A|
|Tipo de publicación||Concesión|
|Fecha de publicación||2 Abr 1974|
|Fecha de presentación||1 May 1972|
|Fecha de prioridad||20 Feb 1970|
|Número de publicación||US 3801675 A, US 3801675A, US-A-3801675, US3801675 A, US3801675A|
|Cesionario original||Johnson & Johnson|
|Exportar cita||BiBTeX, EndNote, RefMan|
|Citada por (39), Clasificaciones (15)|
|Enlaces externos: USPTO, Cesión de USPTO, Espacenet|
\pnl 2, 1974 G. 0. RUSSELL 3,801,675 POLYMER BLEND CONTAINING POLYACRYLIC ACID, POLYVINYL ALCOHOL, AND A POLYACRYLATE Original Filed Feb. 20, 1970 A lOO/o ACRYLIC POLYMER AW AMA B C |oo% |oo% POLYVINYL ALCOHOL POLYACRYLIC ACID United States Patent 3,801,675 POLYMER BLEND CONTAINING POLYACRYLIC ACID, POLYVINYL ALCOHOL, AND A POLY- ACRYLATE Gordon D. Russell, Chateauguay Heights, Quebec, Canada, assignor to Johnson & Johnson Original application Feb. 20, 1970, Ser. No. 13,174, now Patent No. 3,743,536. Divided and this application May 1, 1972, Ser. No. 249,424
Int. Cl. C08f 29/36 US. Cl. 260-901 9 Claims ABSTRACT OF THE DISCLOSURE Absorbent product of improved resistance to discoloration and blocking on sterilization. The product comprises a nonwoven fabric treated with a polycarboxylic acid, a polyvinyl alcohol and an acrylic acid polymer, such as a polyacrylate.
This is a division of application Ser. No. 13,174, filed Feb. 20, 1970, now US. Pat. No. 3,743,536.
This invention relates to absorbent products.
More particularly, this invention relates to absorbent products which are highly absorbent and low in adhesion characteristics suitable for use as surgical sponges.
Surgical sponges are normally composed of several layers of gauze or more recently, one or more layers of nonwoven fabric. The traditional gauze sponges are relatively expensive to manufacture, and unless modified by further treatment, have a tendency to adhere to wounds.
In considering replacement for gauze sponges, non- Woven fabrics have been employed. To a large extent, they overcome the disadvantages of the prior art sponges. However, it has been found that in some cases, nonwoven fabrics tend to block during steam sterilization and have a tendency to become discolored as a result of the sterilization.
With this invention, applicant has developed a novel non-woven sponge which overcomes the disadvantages of the prior art gauze sponges, and at the same time, incorporates all of the advantages of the known non-woven fabrics. Further, the product of the present invention has its own desirable attributes, hereinafter referred to.
According to the present invention, there is provided a non-woven absorbent product, comprising at least one layer of non-woven fabric treated with a binder composition consisting of the mixture of (a) a water soluble high molecular weight alcohol capable of insolubilizing a high molecular weight carboxylic acid, (b) a water soluble high molecular weight polycarboxylic acid, and (c) an acrylic polymer.
It has been found that products in accordance with this invention possess low adhesion to wounds, are not blocked during steam sterilization, are highly absorbent and are softer and more comfortable on a wound. Additionally, the products of the present invention are economical to produce.
The improved properties of the products of the present invention are believed to be attributed to the novel treating composition used, whereby the treating composition imparts to the products the anti-blocking and/or non-discoloration and similar properties. The high molecular weight polycarboxylic acid and the high molecular weight alcohol components are chosen as to be complementary to each other whereby when combined, each has the effect of producing an insolubilized composition.
A preferred alcohol, because of its availability and inexpensiveness is polyvinyl alcohol. Likewise, for the same reasons, a preferred polycarboxylic acid is polyacrylic acid. However, other acids and alcohols having the required properties mentioned above may be employed in accordance with this invention.
The other component of the composition, namely an acrylic polymer, may be any suitable polymer which has the properties, upon being mixed with the other components, of producing a non'hardenable or harsh composition. Typical polymers include polymers of butyl acrylate, ethyl acrylate and mixtures thereof.
The components used in the composition of the present invention may be mixed in any suitable manner to provide the treating product. Preferably, the alcohol and the polycarboxylic acid components are first mixed together and subsequently the resulting mixture blended with the acrylate polymer.
The specific mixture obtained by mixing the three ingredients is believed to form some sort of a reaction product but, the nature of the reaction product or its equilibrium composition in terms of reacted components is not at present fully understood. While not being bound to any particular theory, it is believed that possibly the reaction product is an esterification product which is partially reacted with the methylol groups of the cross-linking acrylate polymer.
In the manufacture of the non-woven fabric, various types of materials can be employed. Typical of these materials are viscose rayon of deniers below 4.5 denier; cuprammonium rayon of deniers below 4.5 denier; cellulose acetate of deniers below 4.5 denier; cotton (bleached absorbent); polyester of deniers below 4.5 denier; and polypropylene of deniers below 4.5 denier. However, it will be understood by those skilled in the art that other materials may also be employed.
It is preferred, but not essential, that the non-woven fabric employed in this invention be stabilized against deterioration by incorporationg into the fabric during its manufacture, a suitable stabilizer known to those skilled in this art. A typical stabilizer is sodium metabisulfite which may be employed in an amount of from about 0.5% to about 1.0%.
A further preferred feature of the present invention, although also not essential, is the addition of a wetting agent to the fabric to increase the wetting speed. Such wetting agents are known to those skilled in the art and include for example di-octyl sodium sulfo-succin-ate which is marketed under the trademark Deceresol GT or Triton GR-S. The wetting agent if included may be present in an amount of from about 0.5 to about one percent by weight.
The non-woven fabrics may be constructed according to known methods of this art as taught by, for example, the procedures taught in Canadian Pat. 653,278.
Preferably, the non-woven fabric is of a foraminous type pattern which resembles a gauze. Such a pattern permits freer passage of fluids and/ or air through the products, enhancing the applicability for use as surgical sponges. However, other non-woven fabric patterns may also be employed while still achieving the desirable attributes of the present invention.
The amount of binder composition incorporated into the non-woven fabrics to provide the fabric with the desirable attributes of the present invention may vary. The amount of binder composition incorporated into the nonwoven fabric, calculated on the basis of a dry solids content, is desirably between 5 and 30%, with a preferred range of 10-15%. However, these figures may vary depending on the particular end product desired.
The binder composition may be applied by any suitable means according to conventional techniques. Such means include passing the non-woven fabric through a bath of the binder composition or alternately, by printing techniques such as by gravure printing. In printing, the complete non-woven fabric need not be printed, but only a certain percentage of ite.g. 35% or less of the fabric surface.
A most preferred composition for use in treating the non-woven fabrics consists of a mixture of three components, namely a cross linking acrylic emulsionsuch as that marketed under the trademark Rhoplex HA-8, a solution of a polyvinyl alcohol and a solution of a polyacrylic acid. Such compositions have been found to provide most effective results when it contains, by Weight, 20 parts acrylic emulsion solids, 1.6 parts polyvinyl alcohol solids and 0.53 part polyacrylic acid solids.
Referring now to the attached drawing, which represents graphically a preferred range of the three component preferred composition of the present invention, point A designates one component-the acrylic polymer, point B the polyvinyl alcohol and point C the acrylic acid component. Points A, B and C each represent a composition consisting of 100 percent by weight of the individual components.
Preferred copolymers of acrylates for use in the present invention include, for example, ethyl acrylate, butyl acrylate and methylol acrylamide which are cross-1inked using heat and catalysts or by heat alone.
The preferred range of materials for the preferred composition is designated within the shaded boundary of the triangular portion A, B and C. Within this area, A represents a composition containing about 93.8%, 4.7% and 1.5% by weight of acrylic polymer, polyvinyl alcohol and acrylic acid respectively. At point B, the composition consists of about 48%, 42% and by weight of acrylic polymer, polyvinyl alcohol and acrylic acid. At point C, the composition consists of about 48%, 34% and 18% by Weight of acrylic polymer, polyvinyl alcohol and acrylic acid.
The surgical sponges of the present invention may include absorbent cores or consist essentially of one or more layers of non-woven fabric folded in a desired manner. If the sponge is fabricated to include a core of absorbent material such as wood pulp fluff or mixtures of Wood pulp fluff fibers, e.g. rayon fibers, such products may be prepared according to conventional proceedings. Similarly, the folding of the nonwoven fabric to provide two or more thicknesses of the material may be accomplished according to techniques known in this art.
The treatment of the products to impart the bonding agents to the non-woven fabrics takes place during the manufacture of the non-woven fabric.
The following examples will demonstrate preferred embodiments of the present invention.
Percent Acrylic polymer (Rhoplex HA-8) 93.8 Polyvinyl alcohol 4.7 Polyacrylic acid (Carbopol 934) 1.5
Crosslinking ethyl acrylate copolymer manufactured by Rohm and Haas Company. Rhoplex is a trademark owned by Rohm & Haas Company.
3 Trademark of Goodrich Company,
The above composition was prepared by mixing the above polyvinyl alcohol solution and the acrylic acid solution in the required proportions. This mixture was then added to the emulsion of the acrylic polymer while stirring.
To treat the fabric, the mixture was applied by gravure printing so as to impart to the fabric, a total dry solids pick-up of about 16% by weight.
The treated fabric was then cut into blanks and folded to form surgical sponges.
Samples of the surgical sponges were then subjected to steam sterilization using saturated steam at a temperature of 225 F. for a period of twenty minutes. After twenty minutes the samples were measured and studied for b ocki g a d discoloration. It was found that there was substantially no blocking and, the sponges had a +b value which was less than 8. As compared to samples which were prepared using different bonding agents of the prior art, and which were subjected to steam sterilization, it was found that such prior art samples were blocked and, had a +b value in excess of 11.
The tests used in determining the discoloration are those known in the art and the value of less than 8 represents a very good product whereas a value in excess of 11 represents considerable discoloration.
It will therefore be seen that applicants products exhibited improved and superior results compared to the prior art.
' EXAMPLE 2 Surgical sponges were produced and as are described in Example 1, but in this case, the example employed included a stabilizer in the amount of about /2 percent by weight of the composition. Again, the products were subjected to the sterilization procedures described and the results of Example 1 were repeated with this product.
EXAMPLE 3 Surgical sponges of the present invention were prepared based on the procedures-of Example 2. The sponges consisted of a sheet of non-woven fabric having a grain Weight of about 350 grains per sq. yd. The non-woven fabric was of the type marketed under the trademark Keybak, Johnson & Johnson. The sponges were treated with the components of Example 2. Two series of such sponges were prepared in which sheet material is formed in the 4" by 4", 8 ply thickness and 4" by 4" 6 ply thickness.
Conventional gauze sponges were also prepared which consisted of several layers of gauze folded to form 4 by 4 inch size products.
The two series of products according to the present invention, and the conventional gauze sponges, were then used in a plurality of repetitive tests to determine their adherence to wounds. As a result of these tests, it was found that wound adherence by the products of the present invention was substantially non-existent, whereas with the conventional gauze sponges, there was evidence of wound adherence in almost all cases.
The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. A composition suitable for improving the char-acteristics of absorbent products comprising a mixture of (a) from 4.7% to 42% of a high molecular weight polyvinyl alcohol, (b) from 1.5% to 18% of a water soluble high molecular weight polycarboxylic acid, and (c) from 48% to 93.8% of a polyacrylate.
2. A composition according to claim 1 wherein said polyacrylate is selected from the group consisting of crosslinking ethyl acrylate homopolymer, butyl acrylate homopolymer, and cross-linking copolymers of ethyl and butyl acrylate.
3. A composition as defined in claim 1 wherein there is included a stabilizer.
4. A composition as defined in claim 3 wherein said stabilizer is sodium metabisulfite.
5. A composition as defined in claim 1, wherein said composition includes a wetting agent.
6. A composition according to claim 1 comprising a mixture of 20 parts by weight of polyacrylate solids, 1.6 parts by weight of polyvinyl alcohol solids and 0.53 part by weight of polyacrylic acid solids.
7. A composition according to claim 1 comprising a mixture of 93.8%, 4.7%, and 1.5% by weight of said polyacrylate, polyvinyl alcohol and polyacrylic acid respectively.
8. A composition according to claim 1 comprising a mixture of 48%, 42%, and 10% by weight of said polyacrylate, polyvinyl alcohol and p ly y c acid res ectively.
5 6 9. A composition according to claim 1 comprising a FOREIGN PATENTS mix f 4 and 13% by weight of said 1 0- 596,750 1/1948 Great Britain 260-901 ac late 1 1 in 1 alcohol and 01 acr lic acid res ecfigy' poyv y P y y P JOHN c. BLEUTGE, Primary Examiner References Cited 5 C. J. SECCURO, Assistant Examiner UNITED STATES PATENTS US. Cl. X.R.
3,253,715 5/1966 Painter etal 117-140A 117138.5, 138.8 B, 138.8 F, 140 A, 143 A; 128-296;
2,773,050 12/1956 Caldwell 260-901 10 26029.6 RW, 29.6 WA
|Patente citante||Fecha de presentación||Fecha de publicación||Solicitante||Título|
|US3853971 *||5 Feb 1974||10 Dic 1974||Nippon Steel Corp||Organic coating composition for an electrical steel sheet|
|US3889678 *||7 Dic 1973||17 Jun 1975||Personal Products Co||Cellulose graft copolymer containing non-ionic and ionic polymer moieties as absorbent media in absorbent dressings|
|US3901843 *||11 Mar 1974||26 Ago 1975||Johnson & Johnson||Synthetic resin binder compositions from acrylic acid esters|
|US3902497 *||25 Mar 1974||2 Sep 1975||American Cyanamid Co||Body absorbable sponge and method of making|
|US4244789 *||24 Ene 1979||13 Ene 1981||Stauffer Chemical Company||Method of metallizing materials|
|US4363840 *||3 Mar 1980||14 Dic 1982||Rhone-Poulenc Industries||Packaging films, sheets and blown or molded hollow bodies|
|US4544698 *||9 Abr 1981||1 Oct 1985||Rhone-Poulenc Industries||Polymer coating composition and its use in the manufacture of layered packaging|
|US4555114 *||31 Oct 1983||26 Nov 1985||William Dozier||Table game puck|
|US4863989 *||26 May 1987||5 Sep 1989||Seitetsu Kagaku Co., Ltd.||Water-absorbent resin composition|
|US4972019 *||20 Jun 1989||20 Nov 1990||Seitetsu Kagaku Co., Ltd.||Water-absorbent resin composition|
|US5552479 *||24 Ene 1994||3 Sep 1996||Kureha Kagaku Kogyo K. K.||Gas barrier film and production process thereof|
|US7371403||23 Dic 2003||13 May 2008||Providence Health System-Oregon||Wound dressing and method for controlling severe, life-threatening bleeding|
|US7482503||14 Jun 2002||27 Ene 2009||Providence Health System-Oregon||Wound dressing and method for controlling severe, life-threatening bleeding|
|US7820872||31 Oct 2007||26 Oct 2010||Providence Health System-Oregon||Wound dressings, apparatus, and methods for controlling severe, life-threatening bleeding|
|US7897832||28 Oct 2005||1 Mar 2011||Hemcon Medical Technologies, Inc.||Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan|
|US8269058||16 Jul 2008||18 Sep 2012||Hemcon Medical Technologies, Inc.||Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan|
|US8313474||17 Dic 2007||20 Nov 2012||Hemcon Medical Technologies, Inc.||Method for preparing a compressed wound dressing|
|US8668924||18 Oct 2010||11 Mar 2014||Providence Health System—Oregon||Wound dressing and method for controlling severe, life-threatening bleeding|
|US8741335||13 Jul 2006||3 Jun 2014||Hemcon Medical Technologies, Inc.||Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan|
|US8920514||20 Dic 2007||30 Dic 2014||Providence Health System—Oregon||Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ|
|US8951565||17 Abr 2014||10 Feb 2015||Hemcon Medical Technologies, Inc.||Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan|
|US9004918||12 Jul 2010||14 Abr 2015||Hemcon Medical Technologies, Inc.||Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan|
|US9132206||5 Ene 2015||15 Sep 2015||Hemcon Medical Technologies, Inc.||Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan|
|US9204957||17 Mar 2005||8 Dic 2015||Hemcon Medical Technologies, Inc.||Systems and methods for hemorrhage control and or tissue repair|
|US9205170||1 May 2009||8 Dic 2015||Hemcon Medical Technologies, Inc.||Wound dressing devices and methods|
|US20040243043 *||23 Dic 2003||2 Dic 2004||Mccarthy Simon J,||Wound dressing and method for controlling severe, life-threatening bleeding|
|US20050038369 *||14 Jun 2002||17 Feb 2005||Gregory Kenton W.||Wound dressing and method for controlling severe, life-threatening bleeding|
|US20050147656 *||23 Dic 2004||7 Jul 2005||Hemcon, Inc.||Tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan|
|US20060004314 *||12 Ago 2005||5 Ene 2006||Hemcon, Inc.||Antimicrobial barriers, systems, and methods formed from hydrophilic polymer structures such as chistosan|
|US20060089584 *||28 Oct 2005||27 Abr 2006||Mcadams Staci A||Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chistosan|
|US20060211973 *||17 Mar 2005||21 Sep 2006||Gregory Kenton W||Systems and methods for hemorrhage control and or tissue repair|
|US20080146984 *||17 Dic 2007||19 Jun 2008||Hemcon Medical Technologies, Inc.||Method for preparing a compressed wound dressing|
|US20080213344 *||18 Abr 2008||4 Sep 2008||Providence Health System- Oregon||Wound dressing and method for controlling severe, life-threatening bleeding|
|US20080287907 *||20 Dic 2007||20 Nov 2008||Providence Health System-Oregan D/B/A Providence St. Vincent Medical Center||Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ|
|US20090018479 *||16 Jul 2008||15 Ene 2009||Hemcon Medical Technologies, Inc.||Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chistosan|
|US20100172958 *||1 May 2009||8 Jul 2010||Hemcon Medical Technologies, Inc.||Wound dressing devices and methods|
|US20110143312 *||12 Jul 2010||16 Jun 2011||Hemcon Medical Technologies, Inc.||Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan|
|WO2005062889A2 *||23 Dic 2004||14 Jul 2005||Hemcon, Inc.||Wound dressing and method for controlling severe, life- threatening bleeding|
|WO2005062889A3 *||23 Dic 2004||20 Abr 2006||Hemcon Inc||Wound dressing and method for controlling severe, life- threatening bleeding|
|Clasificación de EE.UU.||525/57, 524/421, 523/111, 604/369, 604/372|
|Clasificación internacional||D04H1/64, C08L29/04, C08L33/02, C08L33/08|
|Clasificación cooperativa||C08L29/04, C08L33/02, C08L33/08, D04H1/641|
|Clasificación europea||C08L33/08, D04H1/64A|